<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="129382">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01834976</url>
  </required_header>
  <id_info>
    <org_study_id>pchd biomarker in okayama</org_study_id>
    <nct_id>NCT01834976</nct_id>
  </id_info>
  <brief_title>Cardiac Biomarker in Pediatric Heart Disease</brief_title>
  <official_title>Observational Study of Cardiac Biomarker During Perioperative Management in Pediatric Heart Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Okayama University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Okayama University</source>
  <oversight_info>
    <authority>Japan: Ministry of Education, Culture, Sports, Science and Technology</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate cardiac biomarker during perioperative
      management in pediatric cardiac surgery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>serious adverse events</measure>
    <time_frame>one month</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Congenital Heart Disease</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum,urine
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        pediatric patients who receive surgery for congenital heart disease under 18 years old
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  children who receive surgery for congenital heart disease

          -  require cardiopulmonary bypass for surgery

          -  under 18 years old

        Exclusion Criteria:

          -  simple congenital heart disease (atrial septal defect, ventricle septal defect,
             patent ductus arteriosus)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>TOMOYUKI KANAZAWA</last_name>
    <phone>+81862357778</phone>
    <email>tyskanazawa@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>MORITOKI EGI</last_name>
    <phone>+81862357778</phone>
    <email>moriori@tg8.so-net.ne.jp</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Okayama University Hospital</name>
      <address>
        <city>Okayama</city>
        <zip>7008558</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>TOMOYUKI KANAZAWA</last_name>
      <phone>+81862357778</phone>
      <email>tyskanazawa@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>MORITOKI EGI</last_name>
      <phone>+81862357778</phone>
      <email>moriori@tg8.so-net.ne.jp</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <lastchanged_date>April 17, 2013</lastchanged_date>
  <firstreceived_date>April 15, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Okayama University</investigator_affiliation>
    <investigator_full_name>Tomoyuki Kanazawa</investigator_full_name>
    <investigator_title>Pediatric cardiac surgery investigators</investigator_title>
  </responsible_party>
  <keyword>cardiac biomarker</keyword>
  <keyword>congenital heart disease</keyword>
  <keyword>surgery</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Defects, Congenital</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
